Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
2022 · Science · 942 citations
https://doi.org/10.1126/science.abn4947
H
Harry Moultrie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
127
Papers
4.5K
Citations
33
h-index
55
i10-index
Harry Moultrie is an academic researcher from National Health Laboratory Service. The author has contributed to research in topics: HIV/AIDS Research and Interventions & COVID-19 epidemiological studies & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 33, co-authored 108 publications.
ORCID: 0000-0001-9722-0699Papers by this author
worksThe intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
2022 · The Lancet Respiratory Medicine · 289 citations
https://doi.org/10.1016/s2213-2600(22)00092-3
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study
2021 · The Lancet Infectious Diseases · 114 citations
https://doi.org/10.1016/s1473-3099(21)00470-9
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
2022 · Nature Communications · 102 citations
https://doi.org/10.1038/s41467-022-33614-0
Variability of Growth in Children Starting Antiretroviral Treatment in Southern Africa
2012 · PEDIATRICS · 56 citations
https://doi.org/10.1542/peds.2011-3020
Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
2022 · The Lancet · 48 citations
https://doi.org/10.1016/s0140-6736(22)01190-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat